Emerging drugs of abuse: current perspectives on substituted cathinones

References

• BrandtSDFreemanSSumnallHRMeashamFColeJAnalysis of NRG ‘legal highs’ in the UK: identification and formation of novel cathinonesDrug Test Anal20113956957521960541
   PubMed Web of Science ®Google Scholar
• OjanperäLAHeikmanPKRasanenIJUrine analysis of 3,4-methylenedioxypyrovalerone in opioid-dependant patients by gas chromatography-mass spectrometryTher Drug Monitoring201133257263
   PubMed Web of Science ®Google Scholar
• MacherAMPendersTMFalse-positive phencyclidine immunoassay results caused by 3,4-methylenedioxypyrovalerone (MDPV)Drug Test Anal20135213013222611039
   PubMed Web of Science ®Google Scholar
• SwortwoodMJHearnWLDecaprioAPCross-reactivity of designer drugs, including cathinone derivatives, in commercial enzyme-linked immunosorbent assaysDrug Test Anal2013
   Web of Science ®Google Scholar
• McDermottSDPowerJDKavanaghPO’BrienJThe analysis of substituted cathinones. Part 2: an investigation into the phenylacetone based isomers of 4-methylmethcathinone and N-ethylcathinoneForensic Sci Int20112121–3132121775082
   PubMed Web of Science ®Google Scholar
• KavanaghPO’BrienJFoxJThe analysis of substituted cathinones. Part 3. Synthesis and characterisation of 2,3-methylenedioxy substituted cathinonesForensic Sci Int20122161–3192821907509
   PubMed Web of Science ®Google Scholar
• ZubaDAdamowiczPByrskaBDetection of buphedrone in biological and non-biological material – two case reportsForensic Sci Int20132271–3152022981959
   PubMed Web of Science ®Google Scholar
• ArcherRPFluoromethcathinone, a new substance of abuseForensic Sci Int20091851–3102019195800
   PubMed Web of Science ®Google Scholar
• Tor ranceHCooperGThe detection of mephedrone (4-methylmethcathinone) in 4 fatalities in ScotlandForensic Sci Int20102021–3e62e6320685050
   PubMed Web of Science ®Google Scholar
• WymanJFLavinsESEngelhartDPostmortem tissue distribution of MDPV following lethal intoxication by “bath salts”J Anal Toxicol201337318218523408250
   PubMed Web of Science ®Google Scholar
• O’ByrnePMKavanaghPVMcNamaraSMStokesSMScreening of stimulants including designer drugs in urine using a liquid chromatography tandem mass spectrometry systemJ Anal Toxicol2013372647323316030
   PubMed Web of Science ®Google Scholar
• BellCGeorgeCKicmanATTraynorADevelopment of a rapid LC-MS/MS method for direct urinalysis of designer drugsDrug Test Anal201137–849650421744513
   PubMed Web of Science ®Google Scholar
• Strano-RossiSCadwalladerABde la TorreXBotrèFToxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MDPV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometryRapid Commun Mass Spectrom201024182706271420814976
   PubMed Web of Science ®Google Scholar
• MarinettiLJAntonidesHMAnalysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of resultsJ Anal Toxicol201337313514623361867
   PubMed Web of Science ®Google Scholar
• AmbachLHernández RedondoAKönigSWeinmannWRapid and simple LC-MS/MS screening of 64 novel psychoactive substances using dried blood spotsDrug Test Anal Epub2013719
   Google Scholar
• LesiakADMusahRACodyRBDominMADaneAJShepardJRDirect analysis in real time mass spectrometry (DART-MS) of “bath salt” cathinone drug mixturesAnalyst2013138123424343223636110
   PubMed Web of Science ®Google Scholar
• VircksKEMulliganCCRapid screening of synthetic cathinones as trace residues and in authentic seizures using a portable mass spectrometer equipped with desorption electrospray ionizationRapid Commun Mass Spectrom201226232665267223124656
   PubMed Web of Science ®Google Scholar
• WangXVernikovskayaDIAbdelrahmanDRHankinsGDAhmedMSNanovskayaTNSimultaneous quantitative determination of bupropion and its three major metabolites in human umbilical cord plasma and placental tissue using high-performance liquid chromatography-tandem mass spectrometryJ Pharm Biomed Anal20127032032922682512
   PubMed Web of Science ®Google Scholar
• SørensenLKDetermination of cathinones and related ephedrines in forensic whole-blood samples by liquid-chromatography-electrospray tandem mass spectrometryJ Chromatogr B Analyt Technol Biomed Life Sci201187911–12727736
   Web of Science ®Google Scholar
• ZubaDIdentification of cathinones and other active components of “legal highs” by mass spectrometric methodsTrends Anal Chem20123215
   Web of Science ®Google Scholar
• FornalEIdentification of substituted cathinones: 3,4-Methylenedioxy derivatives by high performance liquid chromatography-quadrupole time of flight mass spectrometryJ Pharm Biomed Anal201381821319
   Google Scholar
• SundströmMPelanderAAngererVHutterMKneiselSOjanperäIA high-sensitivity ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry (UHPLC-HR-TOFMS) method for screening synthetic cannabinoids and other drugs of abuse in urineAnal Bioanal Chem2013405268463847423954996
   PubMed Web of Science ®Google Scholar
• GottardoRSorioDMusileGScreening for synthetic cannabinoids in hair by using LC-QTOF MS: A new and powerful approach to study the penetration of these new psychoactive substances in the populationMed Sci Law2014541222723842479
   PubMed Web of Science ®Google Scholar
• AmmannDMcLarenJMGerostamoulosDBeyerJDetection and quantification of new designer drugs in human blood: Part 2 – Designer cathinonesJ Anal Toxicol201236638138922593565
   PubMed Web of Science ®Google Scholar
• MayerMBenkoAHuszárASimultaneous determination of 4-substituted cathinones (4-MMC, 4-MEC and 4-FMC) in human urine by HPLC-DADJ Chromatogr Sci201351986186623192736
   PubMed Web of Science ®Google Scholar
• MeltzerPCButlerDDeschampsJRMadrasBK1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitorsJ Med Chem20064941420143216480278
   PubMed Web of Science ®Google Scholar
• BaumannMHPartillaJSLehnerKRPsychoactive “bath salts”: not so soothingEur J Pharmacol20136981–31523178799
   PubMed Web of Science ®Google Scholar
• EshlemanAJWolfrumKMHatfieldMGJohnsonRAMurphyKVJanowskyASubstituted methcathinones differ in transporter and receptor interactionsBiochem Pharmacol201385121803181523583454
   PubMed Web of Science ®Google Scholar
• SimmlerLDBuserTADonzelliMPharmacological characterization of designer cathinones in vitroBr J Pharmacol2013168245847022897747
   PubMed Web of Science ®Google Scholar
• SogawaCSogawaNOhyamaKMethylone and monoamine transporters: correlation with toxicityCurr Neuropharmacol201191586221886563
   PubMed Web of Science ®Google Scholar
• CameronKKolanosRVekariyaRVerkariyaRDe FeliceLGlennonRAMephedrone and methylenedioxypyrovalerone (MDPV), major constituents of “bath salts,” produce opposite effects at the human dopamine transporterPsychopharmacology (Berl)2013227349349923371489
   PubMed Web of Science ®Google Scholar
• MarusichJAGrantKRBloughBEWileyJLEffects of synthetic cathinones contained in “bath salts” on motor behavior and a functional observational battery in miceNeurotoxicology20123351305131322922498
   PubMed Web of Science ®Google Scholar
• den HollanderBRozovSLindenAMUusi-OukariMOjanperäIKorpiERLong-term cognitive and neurochemical effects of “bath salt” designer drugs methylone and mephedronePharmacol Biochem Behav2013103350150923099177
   PubMed Web of Science ®Google Scholar
• López-ArnauRMartínez-ClementeJCarbóMlPubillDEscubedoECamarasaJAn integrated pharmacokinetic and pharmacodynamic study of a new drug of abuse, methylone, a synthetic cathinone sold as “bath salts”Prog Neuropsychopharmacol Biol Psychiatry201345647223603357
   PubMed Web of Science ®Google Scholar
• ShortallSEMacerolaAESwabyRTBehavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the ratEur Neuropsychopharmacol20132391085109523051939
   PubMed Web of Science ®Google Scholar
• GatchMBTaylorCMForsterMJLocomotor stimulant and discriminative stimulus effects of ‘bath salt’ cathinonesBehav Pharmacol2013245–643744723839026
   PubMed Web of Science ®Google Scholar
• FantegrossiWEGannonBMZimmermanSMRiceKCIn vivo effects of abused ‘bath salt’ constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activityNeuropsychopharmacology201338456357323212455
   PubMed Web of Science ®Google Scholar
• AardeSMHuangPKCreehanKMDickersonTJTaffeMAThe novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in ratsNeuropharmacology20137113014023597511
   PubMed Web of Science ®Google Scholar
• ZelgerJLSchornoHXCarliniEABehavioural effects of cathinone, an amine obtained from Catha edulis Forsk.: comparisons with amphetamine, norpseudoephedrine, apomorphine and nomifensineBull Narc198032367816911034
   PubMedGoogle Scholar
• GlennonRAYousifMNaimanNKalixPMethcathinone: a new and potent amphetamine-like agentPharmacol Biochem Behav19872635475513575369
   PubMed Web of Science ®Google Scholar
• YanagitaTIntravenous self-administration of (-)-cathinone and 2-amino-1-(2,5-dimethoxy-4-methyl)phenylpropane in rhesus monkeysDrug Alcohol Depend1986172–31351413743404
   PubMed Web of Science ®Google Scholar
• GoudieAJImporting khat, legal but dangerousLancet198728571134013412890946
   PubMed Web of Science ®Google Scholar
• SchechterMDRosecransJAGlennonRAComparison of behavioral effects of cathinone, amphetamine and apomorphinePharmacol Biochem Behav19842021811846718445
   PubMed Web of Science ®Google Scholar
• WattersonLRKufahlPRNemirovskyNEPotent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV)Addict Biol2012
   Web of Science ®Google Scholar
• ForresterMBSynthetic cathinone exposures reported to Texas poison centersAm J Drug Alcohol Abuse201238660961522541001
   PubMed Web of Science ®Google Scholar
• EROWID [homepage on the Internet] Available from: http://www.erowid.orgAccessed on: January 5, 2014
   Google Scholar
• Drugs-Forum [homepage on the Internet]SIN Foundation2012 Available from: http://www.drugs-forum.comAccessed on January 5, 2014
   Google Scholar
• SumnallHWoodingOMephedrone: an update on current knowledgeLiverpoolCentre for public health, Liverpool John Moores University2010
   Google Scholar
• ProsserJMNelsonLSThe toxicology of bath salts: a review of synthetic cathinonesJ Med Toxicol201281334222108839
   PubMedGoogle Scholar
• DarganPIAlbertSWoodDMMephedrone use and associated adverse effects in school and college/university students before the UK legislation changeQJM20101031187587920675396
   PubMed Web of Science ®Google Scholar
• WoodDMDarganPIMephedrone (4-methylmethcathinone): what is new in our understanding of its use and toxicityProg Neuropsychopharmacol Biol Psychiatry201239222723322564711
   PubMed Web of Science ®Google Scholar
• SammlerEMFoleyPLLauderGDWilsonSJGoudieARO’RiordanJIA harmless high?Lancet2010376974274220801405
   PubMed Web of Science ®Google Scholar
• Boulanger-GobeilCSt-OngeMLalibertéMAugerPLSeizures and hyponatremia related to ethcathinone and methylone poisoningJ Med Toxicol201281596121755421
   PubMedGoogle Scholar
• NicholsonPJQuinnMJDoddJDHeadshop heartache: acute mephedrone ‘meow’ myocarditisHeart201096242051205221062771
   PubMed Web of Science ®Google Scholar
• JamesDAdamsRDSpearsRNational Poisons Information ServiceClinical characteristics of mephedrone toxicity reported to the UK National Poisons Information ServiceEmerg Med J201128868668920798084
   PubMed Web of Science ®Google Scholar
• LevineMLevitanRSkolnikACompartment syndrome after “bath salts” use: a case seriesAnn Emerg Med201361448048323318022
   PubMed Web of Science ®Google Scholar
• KovácsKTóthARKeresztyEM[A new designer drug: methylone related death]Orv Hetil20121537271276 Hungarian22318528
   PubMedGoogle Scholar
• SchifanoFCorkeryJGhodseAHSuspected and confirmed fatalities associated with mephedrone (4-methylmethcathinone, “meow meow”) in the United KingdomJ Clin Psychopharmacol201232571071422926609
   PubMed Web of Science ®Google Scholar
• RossEAReisfieldGMWatsonMCChronisterCWGoldbergerBAPsychoactive “bath salts” intoxication with methylenedioxypyrovaleroneAm J Med2012125985485822682791
   PubMed Web of Science ®Google Scholar
• StepensAStaggCJPlatkajisABoudriasMHJohansen-BergHDonaghyMWhite matter abnormalities in methcathinone abusers with an extrapyramidal syndromeBrain2010133Pt 123676368421036949
   PubMed Web of Science ®Google Scholar
• SikkKHaldreSAquiloniusSMManganese-induced parkinsonism in methcathinone abusers: bio-markers of exposure and follow-upEur J Neurol201320691592023347399
   PubMed Web of Science ®Google Scholar
• PendersTMLangMCPaganoJJGoodingZSElectroconvulsive therapy improves persistent psychosis after repeated use of methylenedioxypyrovalerone (“bath salts”)J ECT2013294e59e6023609518
   PubMed Web of Science ®Google Scholar
• RothmanRBBaumannMHDerschCMAmphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotoninSynapse2001391324111071707
   PubMed Web of Science ®Google Scholar
• WeeSAndersonKGBaumannMHRothmanRBBloughBEWoolvertonWLRelationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogsJ Pharmacol Exp Ther2005313284885415677348
   PubMed Web of Science ®Google Scholar
• BaumannMHClarkRDWoolvertonWLWeeSBloughBERothmanRBIn vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the ratJ Pharmacol Exp Ther2011337121822521228061
   PubMed Web of Science ®Google Scholar
• BruntTMPoortmanANiesinkRJvan den BrinkWInstability of the ecstasy market and a new kid on the block: mephedroneJ Psychopharmacol201125111543154720826554
   PubMed Web of Science ®Google Scholar
• JohnsonLAJohnsonRLPortierRBCurrent “legal highs”J Emerg Med20134461108111523528960
   PubMed Web of Science ®Google Scholar
• CoppolaMMondolaR3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed onlineToxicol Lett20122081121522008731
   PubMed Web of Science ®Google Scholar
• DerungsASchietzelSMeyerMRMaurerHHKrähenbühlSLiechtiMESympathomimetic toxicity in a case of analytically confirmed recreational use of naphyrone (naphthylpyrovalerone)Clin Toxicol (Phila)201149769169321740148
   PubMed Web of Science ®Google Scholar
• BilińskiPHołowniaPKapka-SkrzypczakLWojtyłaADesigner Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part II--piperazines/piperidines, phenylethylamines, tryptamines and miscellaneous ‘others’Ann Agric Environ Med201219487188223311821
   PubMed Web of Science ®Google Scholar
• CawrseBMLevineBJuferRADistribution of methylone in four postmortem casesJ Anal Toxicol201236643443922582221
   PubMed Web of Science ®Google Scholar
• SpringerDFritschiGMaurerHHMetabolism of the new designer drug alpha-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4′-methyl-alpha-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometryJ Chromatogr B Analyt Technol Biomed Life Sci20037962253266
   PubMed Web of Science ®Google Scholar
• StaackRFMaurerHHMetabolism of designer drugs of abuseCurr Drug Metab20056325927415975043
   PubMed Web of Science ®Google Scholar
• MaurerHHKraemerTSpringerDStaackRFChemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsisTher Drug Monit200426212713115228152
   PubMed Web of Science ®Google Scholar
• PritzkerDKanungoAKilicarslanTTyndaleRFSellersEMDesigner drugs that are potent inhibitors of CYP2D6J Clin Psychopharmacol200222333033212006905
   PubMed Web of Science ®Google Scholar
• CosbeySHPetersKLQuinnABentleyAMephedrone (methylmethcathinone) in toxicology casework: a Northern Ireland perspectiveJ Anal Toxicol2013372748223354334
   PubMed Web of Science ®Google Scholar
• SauerCHoffmannKSchimmelUPetersFTAcute poisoning involving the pyrrolidinophenone-type designer drug 4′-methyl-alpha-pyrrolidinohexanophenone (MPHP)Forensic Sci Int20112081–3e20e2521444164
   PubMed Web of Science ®Google Scholar
• ThorntonSLGeronaRRTomaszewskiCAPsychosis from a bath salt product containing flephedrone and MDPV with serum, urine, and product quantificationJ Med Toxicol20128331031322528592
   PubMedGoogle Scholar
• MartinMMullerJFTurnerKDuezMCirimeleVEvidence of mephedrone chronic abuse through hair analysis using GC/MSForensic Sci Int20122181–3444822041623
   PubMed Web of Science ®Google Scholar
• NameraAUrabeSSaitoTA fatal case of 3,4-methylenedioxypyrovalerone poisoning: coexistence of α-pyrrolidinobutiophenone and α- pyrrolidinovalerophenone on blood and/or hairForensic Toxicol2013312338343
   Web of Science ®Google Scholar
• Mas-MoreyPVisserMHWinkelmolenLTouwDJClinical toxicology and management of intoxications with synthetic cathinones (“bath salts”)J Pharm Pract201326435335723178412
   PubMedGoogle Scholar
• ProsserJMNelsonLSThe toxicology of bath salts: a review of synthetic cathinonesJ Med Toxicol201281334222108839
   PubMedGoogle Scholar
• KasickDPMcKnightCAKlisovicE“Bath salt” ingestion leading to severe intoxication delirium: two cases and a brief review of the emergence of mephedrone useAm J Drug Alcohol Abuse201238217618022221190
   PubMed Web of Science ®Google Scholar
• BlomMTBardaiAvan MunsterBCDifferential changes in QTc duration during in-hospital haloperidol usePLoS One201169e2372821961030
   PubMed Web of Science ®Google Scholar
• Lev-RanSA case of treating cathinone dependence and comorbid depression using bupropionJ Psychoactive Drugs201244543443623457895
   PubMed Web of Science ®Google Scholar
• PendersTMLangMCPaganoJJGoodingZSElectroconvulsive therapy improves persistent psychosis after repeated use of methylenedioxypyrovalerone (“bath salts”)J ECT2013294e59e6023609518
   PubMed Web of Science ®Google Scholar
• WoodDMGreeneSLDarganPIClinical pattern of toxicity associated with the novel synthetic cathinone mephedroneEmerg Med J201128428028220581379
   PubMed Web of Science ®Google Scholar
• SpillerHARyanMLWestonRGJansenJClinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United StatesClin Toxicol (Phila)201149649950521824061
   PubMed Web of Science ®Google Scholar
• TaylorSBLewisCROliveMFThe neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humansSubst Abuse Rehabil20134294324648786
   PubMedGoogle Scholar
• JohnsonLAJohnsonRLPortierRBCurrent “legal highs”J Emerg Med20134461108111523528960
   PubMed Web of Science ®Google Scholar
• GermanCLFleckensteinAEHansonGRBath salts and synthetic cathinones: An emerging designer drug phenomenonLife Sci2013In press
   Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction [webpage on the Internet]EMCDDA: Drug-related topics – Drug profilesLisbonEMCDDA2013 Available from: http://www.emcdda.europa.eu/publications/drug-profilesAccessed January 5, 2014
   Google Scholar
• BruntTMPoortmanANiesinkRJvan den BrinkWInstability of the ecstasy market and a new kid on the block: mephedroneJ Psychopharmacol201125111543154720826554
   PubMed Web of Science ®Google Scholar
• McElrathKO’NeillCExperiences with mephedrone pre- and post-legislative controls: perceptions of safety and sources of supplyInt J Drug Policy201122212012721242082
   PubMed Web of Science ®Google Scholar
• StognerJMMillerBLInvestigating the ‘bath salt’ panic: the rarity of synthetic cathinone use among students in the United StatesDrug Alcohol Rev201332554554923718639
   PubMed Web of Science ®Google Scholar
• ZaitsuKKatagiMKamataHTMikiATsuchihashiHDiscrimination and identification of regioisomeric β-keto analogues of 3,4-methylenedioxyamphetamines by gas chromatography-mass spectrometryForensic Toxicol2008264551
   Web of Science ®Google Scholar
• WestphalFJungeTRing positional differentiation of isomeric N-alkylated fluorocathinones by gas chromatography/tandem mass spectrometryForensic Sci Int20122231–39710522940190
   PubMed Web of Science ®Google Scholar
• AbiedallaYFAbdel-HayKDeRuiterJClarkCRSynthesis and GC-MS analysis of a series of homologs and regioisomers of 3,4-methylenedioxypyrovalerone (MDPV)Forensic Sci Int20122231–318919722995045
   PubMed Web of Science ®Google Scholar
• SpringerDFritschiGMaurerHHMetabolism and toxicological detection of the new designer drug 4′-methoxy-alpha-pyrrolidinopropiophenone studied in rat urine using gas chromatography-mass spectrometryJ Chromatogr B Analyt Technol Biomed Life Sci20037932331342
   Web of Science ®Google Scholar
• GilDAdamowiczPSkulskaATokarczykBStanaszekRAnalysis of 4-MEC in biological and non-biological material – three case reportsForensic Sci Int20132281–3e11e1523562144
   PubMed Web of Science ®Google Scholar
• WikströmMThelanderGNyströmIKronstrandRTwo fatal intoxications with the new designer drug methedrone (4-methoxymethcathinone)J Anal Toxicol201034959459821073814
   PubMed Web of Science ®Google Scholar
• WestphalFJungeTRösnerPFritschiGKleinBGirreserUMass spectral and NMR spectral data of two new designer drugs with an alpha-aminophenone structure: 4′-methyl-alpha-pyrrolidinohexanophenone and 4′-methyl-alpha-pyrrolidinobutyrophenoneForensic Sci Int20071691324216962275
   PubMed Web of Science ®Google Scholar
• BrandtSDWoottonRCDe PaoliGFreemanSThe naphyrone story: The alpha or beta-naphthyl isomer?Drug Test Anal201021049650220886463
   PubMed Web of Science ®Google Scholar
• WestphalFJungeTGirreserUGreiblWDoeringCMass, NMR and IR spectroscopic characterization of pentedrone and pentylone and identification of their isocathinone by-productsForensic Sci Int20122171–315716722115724
   PubMed Web of Science ®Google Scholar
• RojekSKłysMStronaMMaciówMKulaK“Legal highs” – toxicity in the clinical and medico-legal aspect as exemplified by suicide with bk-MBDB administrationForensic Sci Int20122221–3e1e622648055
   PubMed Web of Science ®Google Scholar
• KeshaKBoggsCLRippleMGMethylenedioxypyrovalerone (“bath salts”), related death: case report and review of the literatureJ Forensic Sci20135861654165923822613
   PubMed Web of Science ®Google Scholar
• MaskellPDDe PaoliGSeneviratneCPounderDJMephedrone (4-methylmethcathinone)-related deathsJ Anal Toxicol201135318819121439157
   PubMed Web of Science ®Google Scholar
• PearsonJMHargravesTLHairLSThree fatal intoxications due to methyloneJ Anal Toxicol201236644445122589523
   PubMed Web of Science ®Google Scholar
• CarbonePNCarboneDLCarstairsSDLuziSASudden cardiac death associated with methylone useAm J Forensic Med Pathol2013341262823403480
   PubMed Web of Science ®Google Scholar